Clinical Trials for Drug: PF-02341066

1 Open Trials. Phone:(877.827.8839)
Protocol No. Title Status
UCI-07-40 Phase I Safety, Pharmacokinetic and Pharmacodynamic Study of PF-02341066, a C-MET/HGFR Selective Tyrosine Kinase Inhibitor, Administered Orally to Patients with Advanced Cancer (Appendix T) Open